1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Cognitive Impairment Global Clinical Trials Review, H1, 2014

Cognitive Impairment Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Cognitive Impairment Global Clinical Trials Review, H1, 2014" provides data on the Cognitive Impairment clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cognitive Impairment. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cognitive Impairment. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Cognitive Impairment Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cognitive Impairment 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cognitive Impairment to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cognitive Impairment to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cognitive Impairment 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Cognitive Impairment Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Johnson and Johnson 38
Clinical Trial Overview of Johnson and Johnson 38
Eli Lilly and Company 39
Clinical Trial Overview of Eli Lilly and Company 39
Merck and Co., Inc. 40
Clinical Trial Overview of Merck and Co., Inc. 40
Eisai Co., Ltd. 41
Clinical Trial Overview of Eisai Co., Ltd. 41
AbbVie Inc. 42
Clinical Trial Overview of AbbVie Inc. 42
Takeda Pharmaceutical Company Limited 43
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 43
Shire Plc 44
Clinical Trial Overview of Shire Plc 44
GlaxoSmithKline plc 45
Clinical Trial Overview of GlaxoSmithKline plc 45
Clinical Trial Overview of Top Institutes / Government 46
U.S. Department of Veterans Affairs 46
Clinical Trial Overview of U.S. Department of Veterans Affairs 46
University of Washington 47
Clinical Trial Overview of University of Washington 47
Charite - Universitatsmedizin Berlin 48
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 48
University Hospital Basel 49
Clinical Trial Overview of University Hospital Basel 49
National Institute on Aging 50
Clinical Trial Overview of National Institute on Aging 50
Vanderbilt University 51
Clinical Trial Overview of Vanderbilt University 51
University of Pennsylvania 52
Clinical Trial Overview of University of Pennsylvania 52
Emory University 53
Clinical Trial Overview of Emory University 53
University Hospital, Angers 54
Clinical Trial Overview of University Hospital, Angers 54
National Institute of Mental Health 55
Clinical Trial Overview of National Institute of Mental Health 55
Five Key Clinical Profiles 56
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 106
Contact Us 106
Disclaimer 106
Source 106

List of Tables
Cognitive Impairment Therapeutics, Global, Clinical Trials by Region, 2014* 7
Cognitive Impairment Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cognitive Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Cognitive Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Cognitive Impairment Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cognitive Impairment Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Cognitive Impairment Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cognitive Impairment Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cognitive Impairment Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Cognitive Impairment Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Cognitive Impairment Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Cognitive Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 35
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 37
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 38
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 39
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 40
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 41
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014* 42
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 43
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014* 44
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 45
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 46
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 47
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014* 48
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 49
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2014* 50
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 51
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 52
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 53
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2014* 54
Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 55

List of Figures
Cognitive Impairment Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Cognitive Impairment Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cognitive Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Cognitive Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Cognitive Impairment Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cognitive Impairment Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Cognitive Impairment Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cognitive Impairment Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Cognitive Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
GlobalData Methodology 105

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.